bioRxivImmunology
Characterization of the pscC (Type III secretion) gene of Pseudomonas aeruginosa (PA01) and assessment of immunogenicity of pscC protein in rats
Md Safiul Alam Bhuiyan, Daisy V John, Fernandes Opook, Hafiza Sultana, Kenneth Francis Rodrigues
Abstract
Proteins associated with the bacterial membrane can be recruited for application as antigens for the development of vaccines. This preliminary study was directed towards evaluating the antigenic properties of the Pseudomonas aeruginosa (PA01) pscC protein which is a component of the Type III secretion system. Gene specific primers were designed to isolate the pscC gene which was isolated, ligated onto the multiple cloning site of vector pGS21(a), cloned and expressed in Escherichia coli (BL21). The molecular weight of the expressed pscC protein was determined by SDS-PAGE (10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis) and was found to be around 57 KDa and purified by the size exclusion chromatography. Finally, the purified pscC protein was injected subcutaneously into adult Sprague Dawley(R) rats with a range of concentrations (50, 100 and 150 {micro}g per rat) respectively. Recombinant pscC antigen induced a specific humoral immune response against the antigen, which was validated by Enzyme-linked immunosorbent assay (ELISA). The results concluded that anti-pscC antibody was elicited in the animal model.
- organism: rat
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neutralizing human monoclonal antibodies that target the PcrV component of the Type III Secretion System of Pseudomonas aeruginosa act through distinct mechanisms
Jean-Mathieu Desveaux, Éric Faudry, … Pascal Poignard·bioRxiv·Oct 19, 2024
- Multicomponent Pseudomonas aeruginosa vaccines eliciting Th17 cells and functional antibody responses confer enhanced protection against experimental acute pneumonia in mice
M. O. F. Shaikh, M. M. Schaefers, … G. P. Priebe·bioRxiv·May 5, 2022
- Mucosal vaccine immunity induced by a new auxotrophic Pseudomonas aeruginosa strain is linked to Th17 and IgA responses
Youssouf Sérémé, Bérengère Villeret, … Jean‐Michel Sallenave·bioRxiv·Oct 3, 2025
- Preliminary study on the application of PspA as carrier
Lichan-Wang, Yajun-Tan, … Xiao-Ma·bioRxiv·Apr 20, 2018
- mRNA vaccine induces protective immunity against the type III secretory virulence of Pseudomonas aeruginosa
K. Kawaguchi, M. Kinoshita, … T. Sawa·bioRxiv·Jun 9, 2023
- Isolation and characterization of human monoclonal antibodies to pneumococcal capsular polysaccharide 3
R. Babb, C. R. Doyle, L.-a. Pirofski·bioRxiv·Aug 2, 2021